These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. Aviram M; Bierman EL; Oram JF J Lipid Res; 1989 Jan; 30(1):65-76. PubMed ID: 2918251 [TBL] [Abstract][Full Text] [Related]
3. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. Mendez AJ; Oram JF; Bierman EL J Biol Chem; 1991 Jun; 266(16):10104-11. PubMed ID: 1645339 [TBL] [Abstract][Full Text] [Related]
4. Elevation of cyclic AMP by iloprost and prostaglandin E1 increases cholesterol efflux and the binding capacity for high-density lipoproteins in human fibroblasts. Middleton A; Middleton B Biochim Biophys Acta; 1998 Mar; 1391(2):117-32. PubMed ID: 9554975 [TBL] [Abstract][Full Text] [Related]
5. Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. Slotte JP; Oram JF; Bierman EL J Biol Chem; 1987 Sep; 262(27):12904-7. PubMed ID: 2820959 [TBL] [Abstract][Full Text] [Related]
6. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Oram JF; Mendez AJ; Slotte JP; Johnson TF Arterioscler Thromb; 1991; 11(2):403-14. PubMed ID: 1998658 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of cyclooxygenase isoenzymes by cAMP-elevating agents. Samokovlisky A; Rimon G; Danon A Eur J Pharmacol; 1999 Aug; 378(2):203-11. PubMed ID: 10478633 [TBL] [Abstract][Full Text] [Related]
8. The effect of probucol on HDL-mediated sterol translocation and efflux from cells. Zambon S; Brazg R; Aviram M; Oram JF; Bierman EL Atherosclerosis; 1992 May; 94(1):51-60. PubMed ID: 1632859 [TBL] [Abstract][Full Text] [Related]
9. Efflux of newly synthesized cholesterol and biosynthetic sterol intermediates from cells. Dependence on acceptor type and on enrichment of cells with cholesterol. Johnson WJ; Fischer RT; Phillips MC; Rothblat GH J Biol Chem; 1995 Oct; 270(42):25037-46. PubMed ID: 7559634 [TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-dependent pathway that mediates suppressive regulation of glycosaminoglycan production in cultured vascular endothelial cells. Kaji T; Inada M; Yamamoto C; Fujiwara Y; Koizumi F Thromb Res; 1996 Jun; 82(5):389-97. PubMed ID: 8771699 [TBL] [Abstract][Full Text] [Related]
11. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Rogler G; Trümbach B; Klima B; Lackner KJ; Schmitz G Arterioscler Thromb Vasc Biol; 1995 May; 15(5):683-90. PubMed ID: 7749882 [TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein 3 stimulates phosphatidylcholine breakdown and sterol translocation in rat aortic smooth muscle cells by a phospholipase C/protein kinase C-dependent process. Dusserre E; Pulcini T; Bourdillon MC; Berthezene F Biochem Med Metab Biol; 1994 Jun; 52(1):45-52. PubMed ID: 7917466 [TBL] [Abstract][Full Text] [Related]
13. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. D'Angelo G; Lee H; Weiner RI J Cell Biochem; 1997 Dec; 67(3):353-66. PubMed ID: 9361190 [TBL] [Abstract][Full Text] [Related]
14. Involvement of cyclic adenosine monophosphate-dependent protein kinase isozymes in tissue plasminogen activator secretion by rat Sertoli cells stimulated with follicle-stimulating hormone in vitro. Laurent-Cadoret V; Guillou F; Combarnous Y Acta Endocrinol (Copenh); 1993 Jun; 128(6):555-62. PubMed ID: 7687808 [TBL] [Abstract][Full Text] [Related]
15. cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1. Hoang T; Fenne IS; Cook C; Børud B; Bakke M; Lien EA; Mellgren G J Biol Chem; 2004 Nov; 279(47):49120-30. PubMed ID: 15347661 [TBL] [Abstract][Full Text] [Related]
16. Effect of forskolin, isoproterenol and IBMX on angiotensin converting enzyme and cyclic AMP production by cultured bovine endothelial cells. Cary DA; Mendelsohn FA Mol Cell Endocrinol; 1987 Sep; 53(1-2):103-9. PubMed ID: 2444475 [TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP stimulates the synthesis and function of the low-density lipoprotein receptor in human vascular smooth-muscle cells and fibroblasts. Middleton B; Middleton A Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):853-61. PubMed ID: 1313231 [TBL] [Abstract][Full Text] [Related]
18. Myosin phosphatase and cofilin mediate cAMP/cAMP-dependent protein kinase-induced decline in endothelial cell isometric tension and myosin II regulatory light chain phosphorylation. Goeckeler ZM; Wysolmerski RB J Biol Chem; 2005 Sep; 280(38):33083-95. PubMed ID: 16055445 [TBL] [Abstract][Full Text] [Related]
19. Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Sprague RS; Ellsworth ML; Stephenson AH; Lonigro AJ Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1158-64. PubMed ID: 11546651 [TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells. Giasson E; Servant MJ; Meloche S J Biol Chem; 1997 Oct; 272(43):26879-86. PubMed ID: 9341120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]